Acadian Asset Management
LPCN icon

Acadian Asset Management’s Lipocine LPCN Stock Holding History

Acadian Asset Management’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-83
Closed – – 1762
2023
Q2 		$0 Sell
83
-623
-88% -$2.93K ﹤0.01% 1831
2023
Q1 		$3K Sell
706
-4,298
-86% -$33.2K ﹤0.01% 1702
2022
Q4 		$32K Hold
5,004
– – ﹤0.01% 1650
2022
Q3 		$37K Hold
5,004
– – ﹤0.01% 1535
2022
Q2 		$68K Buy
+5,004
New +$78K ﹤0.01% 1444
2019
Q2 		– Sell
-1,056
Closed -$41K – 1946
2019
Q1 		$41K Buy
+1,056
New +$32.4K ﹤0.01% 1716

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management's LPCN Position: Q3 2023 in Review

Acadian Asset Management sold out of Lipocine (LPCN) in Q3 2023, closing a stake of 83 shares.

Acadian Asset Management first reported a position in LPCN in Q1 2019 and held it in 6 quarters. The position peaked at $68K in Q2 2022. 21 funds tracked by Wall St. Rank hold LPCN as of Q3 2023.

  • Acadian Asset Management reported no remaining Lipocine position as of Q3 2023 after selling out during the quarter.
  • Acadian Asset Management sold 83 Lipocine shares in Q3 2023.
  • Acadian Asset Management first reported a position in Lipocine in Q1 2019 and held it in 6 quarters.
  • Acadian Asset Management's Lipocine position peaked at $68K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Lipocine as of Q3 2023.

Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.